Skip to main content
Clinical Trials/NCT06461923
NCT06461923
Recruiting
Not Applicable

Development and Feasibility Study of the Home-based Gait Rehabilitation Service by Using the Insole-type Gait Analysis Device for Children With Cerebral Palsy

Yonsei University1 site in 1 country10 target enrollmentAugust 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gait Disorders, Neurologic
Sponsor
Yonsei University
Enrollment
10
Locations
1
Primary Endpoint
6-minute Walking Test
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Walking is a crucial daily activity that requires complex coordination of muscular systems. It is essential for bone and muscle health, cardiovascular fitness, and activities of daily living, making it an important indicator of prognosis and patient function. Insole gait analysis devices are affordable and easy to use, and they align well with standardized 3D gait analysis. However, their use outside of hospital settings is limited.

This study aims to assess the usability and satisfaction of utilizing insole gait analysis devices for monitoring and providing feedback on the walking status of children with cerebral palsy exhibiting walking impairments in a home environment. Additionally, adherence to a home-based exercise program developed in this study will be evaluated.

Detailed Description

The screening test is conducted after obtaining consent, and it involves assessing whether the subject can independently walk more than 10 meters, regardless of the use of assistive devices, following an evaluation of their baseline symptoms and signs. Subjects who pass the screening test are provided with information about their current walking status and what constitutes normal walking. Following the initial evaluation, they are instructed to participate in the 6-week home exercise program and how to record an exercise log. Additionally, researchers provide participants with an insole gait analysis device and instruct them on its operation, encouraging prolonged usage to ensure that usage time and walking patterns are recorded. Based on the collected measurement data, feedback is provided over the phone at weeks 3 to 4. After completing the 6-week home exercise program, a final evaluation is conducted in the same manner as the initial evaluation. Satisfaction with the insole gait analysis device is assessed only at the time of the final evaluation. Usage and satisfaction with the insole gait analysis device will be analyzed, and evaluation indicators will be compared before and after the home exercise program. Additionally, adherence to the home exercise program will be evaluated through exercise logs.

Registry
clinicaltrials.gov
Start Date
August 1, 2024
End Date
June 2025
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with cerebral palsy aged 7 to 18 years old
  • Patients classified as Gross Motor Function Classification System level 1 or 2
  • Individuals who visited Severance Hospital, comprehended the study, agreed to participate, and submitted the informed consent form

Exclusion Criteria

  • Individuals with complications such as severe foot deformities where the sensors of the insole gait analysis device cannot be recognized
  • In addition to above, individuals with clinically significant findings deemed inappropriate for this study by the study director or person in charge based on medical judgment

Outcomes

Primary Outcomes

6-minute Walking Test

Time Frame: This test results will be assessed two times: baseline and after 6 weeks

Secondary Outcomes

  • Calories burned (kcal)(This test results will be assessed two times: baseline and after 6 weeks)
  • Walking speed (m/s)(This test results will be assessed two times: baseline and after 6 weeks)
  • Stride length (cm)(This test results will be assessed two times: baseline and after 6 weeks)
  • Korean version of Cerebral Palsy Quality of Life (scores)(This test results will be assessed two times: baseline and after 6 weeks)
  • Appendicular muscle mass (kg)(This test results will be assessed two times: baseline and after 6 weeks)
  • Weight (kg)(This test results will be assessed two times: baseline and after 6 weeks)
  • Grip Strength Test (kg)(This test results will be assessed two times: baseline and after 6 weeks)
  • 10-meter Walking Test (m/s)(This test results will be assessed two times: baseline and after 6 weeks)
  • Korean version of KIDSCREEN-52 (Parents) (scores)(This test results will be assessed two times: baseline and after 6 weeks)
  • Satisfaction Survey for the Device (scores)(This test results will be assessed once: after 6 weeks)
  • The number of steps (n)(This test results will be assessed two times: baseline and after 6 weeks)
  • Activity time (min)(This test results will be assessed two times: baseline and after 6 weeks)
  • Pediatric Balance Scale (scores)(This test results will be assessed two times: baseline and after 6 weeks)
  • Gross Motor Function Classification System (levels)(This test results will be assessed two times: baseline and after 6 weeks)
  • Height (cm)(This test results will be assessed two times: baseline and after 6 weeks)
  • Left-right gait balance (%)(This test results will be assessed two times: baseline and after 6 weeks)
  • Activity distance (km)(This test results will be assessed two times: baseline and after 6 weeks)
  • Korean version of KIDSCREEN-52 (Children & Adolescents) (scores)(This test results will be assessed two times: baseline and after 6 weeks)

Study Sites (1)

Loading locations...

Similar Trials